506260 — Anuh Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹11.04bn
- IN₹10.42bn
- IN₹6.47bn
- 90
- 29
- 90
- 85
Annual cashflow statement for Anuh Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 192 | 386 | 391 | 475 | 783 |
| Depreciation | |||||
| Non-Cash Items | 12.7 | -76.5 | -37.9 | -53.1 | -112 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 215 | -647 | -184 | 20.4 | -628 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 489 | -187 | 289 | 539 | 129 |
| Capital Expenditures | -356 | -61.5 | -16.1 | -15.5 | -50.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -409 | 584 | -62 | -419 | 59.3 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -765 | 522 | -78.2 | -435 | 9.18 |
| Financing Cash Flow Items | -5.65 | -16 | -10.7 | -1.2 | -2.48 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 222 | -331 | -194 | -123 | -85.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -54.3 | 3.53 | 16 | -18.7 | 52.7 |